Arrowhead Research
ARWR • NASDAQ
Arrowhead Research is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher R. Anzalone, with a market cap of $8.1B.
Market Cap$8.1B
Employees525.0
CEOChristopher R. Anzalone
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ2 2026
Financials
Arrowhead Research FAQ
Common questions about Arrowhead Research
Arrowhead Research is scheduled to report earnings for Q2 2026 on May 11, 2026. Analysts estimate revenue of $79.7M.
Arrowhead Research has approximately 525 employees.